📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
27
Warrant Exposure
70
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
39%
📜 Warrant Exercise
40%
• Significant warrants: 22% of shares outstanding
• Elevated warrant risk score (70/100)
📉 Score Deterioration
40%
• Score rose 27 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($38M, 9% of market cap)
• Active ATM program with $38M remaining capacity
💹 Market Data
Market Cap$432.45M
Shares Outstanding127.19M
Float100.41M
Cash$231.01M
Debt$436.26M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 22.8% shares (2025Q4 vs prior)
113 institutional holders · 85.13M shares
#1
Redmile Group, LLC
15.67M shares
#2
TCG Crossover Management, LLC
11.39M shares
#3
Prosight Management, LP
8.48M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest5.75M
Days to Cover4.0
% of Float5.7%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2022
424B3
ATM
Apr 15, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
EFFECT
EFFECT
Mar 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ADCT
📊 ADCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ADCT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.